FT
Fiduciary Trust Portfolio holdings
AUM
$8.13B
1-Year Return
17.24%
This Quarter Return
-16.79%
1 Year Return
+17.24%
3 Year Return
+70.37%
5 Year Return
+113.33%
10 Year Return
+243.4%
AUM
$3.45B
AUM Growth
-$842M
(-20%)
Cap. Flow
-$29.3M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
37.02%
Holding
544
New
30
Increased
174
Reduced
225
Closed
48
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$20.5M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$9.44M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
$7.17M |
| 4 |
Vanguard Total World Stock ETF
VT
|
$5.55M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$4.74M |
Top Sells
Sector Composition
| 1 | Technology | 14.43% |
| 2 | Healthcare | 12.8% |
| 3 | Consumer Discretionary | 8.95% |
| 4 | Financials | 5.58% |
| 5 | Consumer Staples | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Lockheed Martin
LMT
$108B
| $1.8M | 0.05% |
5,300
+146
| +3% | +$49.5K |
|
202
Cboe Global Markets
CBOE
$24.3B
| $1.79M | 0.05% |
20,086
+1,301
| +7% | +$116K |
|
203
iShares Core US Aggregate Bond ETF
AGG
$131B
| $1.77M | 0.05% |
15,373
-177
| -1% | -$20.4K |
|
204
Moody's
MCO
$89.5B
| $1.76M | 0.05% |
8,340
| – | – |
|
205
SPDR S&P MidCap 400 ETF Trust
MDY
$24B
| $1.76M | 0.05% |
6,686
+3,749
| +128% | +$986K |
|
206
Target
TGT
$42.3B
| $1.7M | 0.05% |
18,302
-20
| -0.1% | -$1.86K |
|
|
UN
207
DELISTED
Unilever NV New York Registry Shares
UN
| $1.7M | 0.05% |
34,884
-5,235
| -13% | -$255K |
|
208
Entergy
ETR
$39.2B
| $1.68M | 0.05% |
35,854
+432
| +1% | +$20.3K |
|
209
Truist Financial
TFC
$60B
| $1.68M | 0.05% |
54,544
-8,575
| -14% | -$264K |
|
210
Baxter International
BAX
$12.5B
| $1.65M | 0.05% |
20,306
-680
| -3% | -$55.2K |
|
211
Salesforce
CRM
$239B
| $1.64M | 0.05% |
11,390
+442
| +4% | +$63.6K |
|
212
Stanley Black & Decker
SWK
$12.1B
| $1.64M | 0.05% |
16,391
+2,272
| +16% | +$227K |
|
213
Sherwin-Williams
SHW
$92.9B
| $1.64M | 0.05% |
10,689
-612
| -5% | -$93.7K |
|
214
Microchip Technology
MCHP
$35.6B
| $1.63M | 0.05% |
48,174
+338
| +0.7% | +$11.5K |
|
215
Ball Corp
BALL
$13.9B
| $1.61M | 0.05% |
24,850
+5,915
| +31% | +$382K |
|
|
MYOK
216
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.6M | 0.05% |
34,016
-4,148
| -11% | -$194K |
|
217
Eli Lilly
LLY
$652B
| $1.58M | 0.05% |
11,356
+364
| +3% | +$50.5K |
|
218
iShares Russell Mid-Cap ETF
IWR
$44.6B
| $1.54M | 0.04% |
35,720
+15,748
| +79% | +$680K |
|
219
Schwab International Equity ETF
SCHF
$50.5B
| $1.53M | 0.04% |
+118,078
| New | +$1.53M |
|
220
Nuveen ESG Mid-Cap Growth ETF
NUMG
$410M
| $1.51M | 0.04% |
51,523
+2,368
| +5% | +$69.3K |
|
221
Fulcrum Therapeutics
FULC
$414M
| $1.49M | 0.04% |
124,999
+104,999
| +525% | +$1.25M |
|
222
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.42B
| $1.49M | 0.04% |
+24,012
| New | +$1.49M |
|
223
Biogen
BIIB
$20.6B
| $1.45M | 0.04% |
4,577
+98
| +2% | +$31K |
|
224
FTI Consulting
FCN
$5.46B
| $1.44M | 0.04% |
12,000
| – | – |
|
225
Voyager Therapeutics
VYGR
$235M
| $1.42M | 0.04% |
155,343
| – | – |
|